LMCG Investments’s Teva Pharmaceuticals TEVA Stock Holding History

LMCG Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$420K	Sell	7,447 -5	-0.1%	-$324	0.01%	481
2015 Q2	$440K	Hold	7,452	–	–	0.01%	475
2015 Q1	$464K	Hold	7,452	–	–	0.01%	461
2014 Q4	$429K	Sell	7,452 -313	-4%	-$17.4K	0.01%	426
2014 Q3	$417K	Buy	7,765 +1,968	+34%	+$104K	0.01%	419
2014 Q2	$304K	Sell	5,797 -591	-9%	-$30.2K	0.01%	434
2014 Q1	$338K	Sell	6,388 -400	-6%	-$18.5K	0.01%	430
2013 Q4	$272K	Sell	6,788 -950	-12%	-$37.4K	0.01%	449
2013 Q3	$292K	Hold	7,738	–	–	0.01%	424
2013 Q2	$303K	Buy	+7,738	New	+$301K	0.01%	426

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LMCG Investments's TEVA Position: Q3 2015 in Review

LMCG Investments reduced its Teva Pharmaceuticals (TEVA) stake by 0.07% in Q3 2015, selling an estimated $324 and leaving 7,447 shares worth $420K. The position accounts for 0.01% of the portfolio, ranked #481.

LMCG Investments first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $464K in Q1 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

LMCG Investments held 7,447 shares of Teva Pharmaceuticals worth $420K as of Q3 2015.
LMCG Investments sold 5 Teva Pharmaceuticals shares in Q3 2015, an estimated $324.
Teva Pharmaceuticals made up 0.01% of LMCG Investments's portfolio in Q3 2015, its #481 holding.
LMCG Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
LMCG Investments's Teva Pharmaceuticals position peaked at $464K in Q1 2015.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.